·The Hindu

India missed its 2025 TB elimination target. What does the WHO report show?

FlashcardsQuick reviseKey facts. One by one.Start →
In this note
  1. At a Glance
  2. Why in the News
  3. Background & Evolution
  4. Core Static Facts
  5. Multi-Dimensional Analysis
  6. Recent Developments (last 12–18 months)
  7. Prelims Hooks
  8. How Far India Really Was From the Target
  9. Why Finding More Patients Did Not Mean Fewer New Cases
  10. Why TB Treatment Is Free but Having TB Is Still Costly
  11. Was the 2025 Target a Mistake?
  12. What the Next TB Plan Should Change
  13. Anchors for Answers
  14. Mains Relevance
  15. Related Topics to Study Next
  16. NCERT Concepts to Revise
  17. Common Errors / Trap Areas
Practice
8 questions on this article
Check the answer for each question, or reveal all at once.
Practice MCQs →

1. At a Glance

  • India set itself the goal of eliminating TB by 2025, five years earlier than the global SDG deadline of 2030. The goal was built into the National Strategic Plan (NSP) for TB Elimination 2017–2025. India has missed it. [1]
  • The WHO Global Tuberculosis Report 2026 came out on 12 November 2026. It shows India still carries nearly a quarter of the world's TB burden, even though diagnosis and treatment have expanded. [1]
  • India did better on deaths than on new cases. TB mortality fell 38% between 2015 and 2025. WHO has withheld India's 2025 incidence estimate while it reviews new surveillance data. [1]
  • Why it matters for UPSC: this topic touches health governance (GS-II), the gap between targets and results, how disease surveillance and data credibility work, SDG 3, and the shift from donor money to domestic funding.

2. Why in the News

  • The WHO Global TB Report 2026 was released on 12 November 2026. It covers data for calendar year 2025, the year India's elimination target fell due. [1]
  • The report did not publish India's estimated TB incidence for 2025. The figures are under review "pending an assessment of new surveillance data". [1]
  • India diagnosed and notified 25.3 lakh TB cases in 2025. [1]
  • A linked report in The Hindu says domestic spending now makes up 86% of TB funding as external funding falls (WHO report). [1]

3. Background & Evolution

  • SDG 3.3: end the TB epidemic by 2030. India chose to aim for 2025. [1]
  • NSP for TB Elimination 2017–2025: this plan moved India's policy from disease control to disease elimination. It is organised around four pillars: Detect – Treat – Prevent – Build (DTPB). [3][4]
  • 2020: the Revised National TB Control Programme (RNTCP) was renamed the National TB Elimination Programme (NTEP). The new name reflects the aim of eliminating TB by 2025. [3][4]
  • 9 September 2022: the President of India launched the Pradhan Mantri TB Mukt Bharat Abhiyaan. It is a community-support part of the NTEP that gives TB patients extra help (nutrition, diagnostics, vocational support) through donors called "Ni-kshay Mitras". [4]
  • 100-Day intensified TB campaign: run under the NTEP within the National Health Mission (NHM) and aligned with the NSP 2017–2025. (Launch date not confirmed from whitelisted sources in this session.)
  • November 2025: the WHO Global TB Report 2025 was released. WHO said the South-East Asia Region leads global TB cases and urged faster action to close gaps. [2][5]

4. Core Static Facts

Item Fact
National target year 2025 (global SDG target: 2030) [1]
Governing plan NSP for TB Elimination 2017–2025 [1][3]
NSP incidence target Cut from 217 per lakh (2015) to 43 per lakh (2025), an 80% reduction [1]
NSP pillars Detect – Treat – Prevent – Build (DTPB) [3]
Programme NTEP (renamed from RNTCP in 2020) [3][4]
Ministry Ministry of Health & Family Welfare (DGHS / Central TB Division) [3][4]
Funding platform NTEP runs under the National Health Mission [3]
Community initiative PM TB Mukt Bharat Abhiyaan, launched 9 Sept 2022 by the President [4]
India TB deaths per lakh 28 (2015) → 18 (2025), a fall of 38% [1]
WHO 2020 milestone 35% cut in TB deaths versus 2015. India passed it, but five years late [1]
India notifications, 2025 25.3 lakh [1]
India's share of global burden About one-quarter [1]
Global incidence, 2025 About 10.6 million people developed TB [1]
India's 2025 incidence Not published by WHO; under review [1]
Funding mix Domestic spending 86%; external funding falling [1]

5. Multi-Dimensional Analysis

Administrative / Governance

  • The 2025 target was very ambitious. It required an 80% cut in incidence in 10 years (217 → 43 per lakh). [1]
  • More notifications (25.3 lakh in 2025) show better case-finding. That alone does not mean transmission has fallen. Notifications and incidence measure different things. [1]
  • WHO withholding India's incidence estimate shows that surveillance quality and data validation now decide how credible a country's claims of progress are. [1]

Health / Scientific

  • Mortality fell faster than incidence data can confirm (38% fall in deaths). This points to earlier diagnosis and better treatment. It also suggests that prevention and reduced transmission are where India is behind. [1]
  • The new estimate depends on new surveillance data. This is a move away from pure modelling towards estimates grounded in field data. [1]
  • The NSP's "Prevent" pillar (preventing TB infection from turning into disease, and cutting transmission) is the weakest link in reaching incidence targets. [3]

Economic / Fiscal

  • Domestic funding (86%) now dominates as donor money shrinks. This tests whether India can sustain TB financing through the NHM and states. [1]
  • India carries about a quarter of the global burden, so its spending decisions strongly shape global End-TB financing gaps. [1]

Social

  • TB is a disease of poverty: undernutrition, crowded housing and informal work drive it. Community-led nutritional and social support through the TB Mukt Bharat Abhiyaan tries to tackle these causes. [4]
  • Patients who are missed (notified cases are fewer than true incidence) are often from private-sector, urban-poor or remote populations. This is an equity concern. [1]

Geopolitical / Multilateral

  • India sets the trend for the WHO South-East Asia Region, which leads global TB cases. [2]
  • Setting a 2025 goal ahead of the SDG deadline was a global leadership signal. Missing it affects India's credibility in health diplomacy. [1]

6. Recent Developments (last 12–18 months)

  • November 2025: the WHO Global TB Report 2025 was released. WHO stressed that the South-East Asia Region leads global TB cases and urged faster action. [2][5]
  • December 2025: the NSP 2017–2025 period ended, and the national 2025 elimination target was missed. [1]
  • 12 November 2026: the WHO Global TB Report 2026 was released. It reported about 10.6 million global cases in 2025 and a 38% fall in India's TB mortality since 2015. [1]
  • November 2026: India's 2025 incidence estimate was withheld, pending an assessment of new surveillance data. [1]
  • 2026: domestic funding reached 86% of TB spending as external aid declined (WHO). [1]

7. Prelims Hooks

  • India's national TB elimination target year was 2025. The SDG target year is 2030. [1]
  • India's governing plan was the National Strategic Plan for TB Elimination 2017–2025. [1]
  • The NSP aimed to cut TB incidence from 217 to 43 per lakh, an 80% reduction, between 2015 and 2025. [1]
  • NSP pillars: Detect – Treat – Prevent – Build (DTPB). [3]
  • RNTCP was renamed NTEP in 2020. [3][4]
  • PM TB Mukt Bharat Abhiyaan was launched by the President of India on 9 September 2022. [4]
  • The WHO Global TB Report 2026 was released on 12 November 2026. [1]
  • India's TB mortality fell from 28 to 18 deaths per lakh between 2015 and 2025, a 38% decline. [1]
  • The WHO End TB milestone for 2020 was a 35% reduction in TB deaths versus 2015. India achieved it five years late. [1]
  • India notified 25.3 lakh TB cases in 2025. [1]
  • About 10.6 million people developed TB worldwide in 2025. [1]
  • India accounts for nearly one-quarter of the global TB burden. [1]
  • WHO did not publish India's 2025 TB incidence estimate. [1]
  • Domestic sources fund 86% of TB spending as external funding declines. [1]
  • The NTEP is implemented under the National Health Mission (MoHFW). [3]

8. How Far India Really Was From the Target

  • India's incidence was more than four times the target, one year before the deadline
  • Incidence means the number of new TB cases each year per lakh people. It is different from notification, which counts only the cases that get reported.
  • The government's own figures say incidence fell from 237 per lakh in 2015 to 187 per lakh in 2024. That is a 21% fall [6].
  • The NSP target for 2025 was 43 per lakh [1]. To reach it, incidence would have had to fall by more than three-quarters in a single year.
  • So India did not just miss the target by a little in 2025. It was already far off course by 2024.

  • The 2015 starting point has itself changed, so compare like with like

  • The NSP was written using a 2015 starting figure of 217 per lakh [1]. The government's 2024 release uses 237 per lakh for the same year [6].
  • WHO updates its old estimates when new data come in. The 2015 number moved, but the 2025 target stayed where it was.
  • In an answer, do not set the 217 starting figure against the 187 figure for 2024. Each one comes from a different set of estimates.

  • Slow, but faster than the rest of the world

  • The Health Ministry says India's 21% fall is almost double the global fall of 12% over the same years [7].
  • Both statements are true together: India did better than the world average, and it was still far from its own target.

9. Why Finding More Patients Did Not Mean Fewer New Cases

  • About 4 in 10 patients found in the 100-day campaign had no symptoms
  • The 100-day campaign began on 7 December 2024. It screened 12.97 crore people in high-risk districts and found 7.19 lakh TB patients [10].
  • 2.85 lakh of these patients were asymptomatic, meaning they had no cough or fever to make them visit a doctor [10].
  • The normal programme waits for people with symptoms to come in. It cannot find these patients, but they can still spread TB to others.

  • Active search pushes the case count up before it pulls new cases down

  • When workers go out looking with X-ray machines, they find cases that already existed but were hidden. So notifications go up first.
  • Transmission falls only later, because each patient found early stops infecting the people around them.
  • This is why the rise to 25.3 lakh notified cases [1] cannot be read as proof that fewer people are catching TB.

  • The campaign showed what works, but a campaign ends after 100 days

  • The large share of hidden cases suggests the normal system misses many patients.
  • When a campaign stops, these patients go unfound again until symptoms appear.

10. Why TB Treatment Is Free but Having TB Is Still Costly

  • Free medicine does not protect a family from financial ruin
  • WHO says about half of TB patients and their families face catastrophic costs [11]. That means total costs of more than 20% of household income.
  • These costs include lost wages, travel to the clinic and extra food, not just medicine.
  • The End TB Strategy target is zero families facing such costs [11]. Today the world is close to 50%.

  • Nutrition support is small and short

  • Under the Ni-kshay Poshan Yojana, the government doubled cash support from ₹500 to ₹1,000 a month for the whole treatment period, from 1 November 2024 [9].
  • Energy-dense nutritional supplementation (extra high-calorie food) is given only to underweight patients, with a BMI below 18.5, and only for the first two months [9].
  • A patient who is just above that BMI line, or who is in month three, gets only the cash.

  • Help from donors depends on goodwill

  • In September 2023, a parliamentary committee said the Ni-kshay Mitra model, in which donors adopt TB patients, cannot be the mainstay of TB elimination [8].
  • The reason is that donors choose whether to help, and how much. A patient in a district with few donors can get less than a patient in a district with many.

11. Was the 2025 Target a Mistake?

  • The strongest case against the target
  • Its critics warned early on that it was unrealistic. In 2019, the Global Fund called ending TB in India by 2025 a tough task [13].
  • A target that everyone knows is out of reach can make officials stop trusting it. In 2023, a parliamentary committee raised concern about complacency in the Health Ministry [8].
  • A target set too high also creates pressure to make the numbers look good. WHO has now held back India's 2025 incidence estimate while it checks new data [1], so the question of data credibility is now out in the open.

  • The answer: the target brought real gains

  • With the target came the programme's new name (NTEP), the PM TB Mukt Bharat Abhiyaan and the 100-day campaign [3][4][10].
  • Deaths fell by 38% [1], and incidence fell almost twice as fast as the world average [7].

  • What critics get right

  • A target that shows only a pass or fail on the deadline hides the progress made along the way, and India now looks like it has failed.
  • Clear yearly milestones, checked by independent data, would have shown earlier that India was off track. By 2024, incidence was still 187 per lakh [6].

12. What the Next TB Plan Should Change

  • MoHFW should make X-ray screening of high-risk groups a year-round service, not a one-time campaign
  • The 100-day campaign found 2.85 lakh patients who had no symptoms [10].
  • Making this screening regular would catch patients early and every year, not just once.

  • The Central TB Division should turn nutrition support into a right, not a favour from donors

  • The parliamentary committee said the Ni-kshay Mitra model cannot carry the programme [8].
  • Supplementation could cover all undernourished patients for the whole of treatment, not only those below BMI 18.5 for two months [9].

  • The new plan should track catastrophic costs, not only cases and deaths

  • WHO's End TB target is that no family faces catastrophic costs, but about half do today [11].
  • If this is not measured, India can cut deaths and still leave families in poverty.

  • MoHFW should review the old plan openly before writing the new one

  • Down To Earth has called for a review of the 2017–2025 plan as it ends [12].
  • Publishing the survey methods behind India's estimates would help WHO check and accept the figures it is now holding back [1].

  • States must fill the gap left by donors

  • Domestic money now pays for 86% of TB spending, and donor money is falling [1].
  • Because the NTEP runs through the National Health Mission [3], state budgets will decide whether campaigns like the 100-day drive can continue.

13. Anchors for Answers

  • Data: TB incidence fell 21%, from 237 to 187 per lakh (2015–2024), against an NSP target of 43 per lakh [6][1]
  • Data: 2.85 lakh of the 7.19 lakh patients found in the 100-day campaign had no symptoms [10]
  • Data: About half of TB patients and their families face catastrophic costs (above 20% of household income) [11]
  • Report/Committee: Parliamentary committee (September 2023): the Ni-kshay Mitra model cannot be the mainstay of TB elimination [8]; WHO Global TB Report 2026 held back India's 2025 incidence estimate [1]
  • Comparison: India's incidence fell 21% against 12% worldwide over the same years [7]
  • Scheme: Ni-kshay Poshan Yojana, raised to ₹1,000 a month from 1 November 2024 [9]; 100-day TB campaign launched 7 December 2024 [10]

14. Mains Relevance

  • GS-II: Issues relating to development and management of the Social Sector/Services relating to Health; Government policies and interventions; Important international institutions (WHO).
  • GS-III: Science & Technology in everyday life (diagnostics, surveillance); inclusive growth (health financing).
  • GS-IV (case angle): whether health data is reported honestly and openly, and who is accountable for public targets.

Possible question stems:

  1. India achieved notable gains in TB mortality but missed its 2025 elimination target. Examine the structural reasons for the gap between case notification and incidence reduction. (GS-II, 15 marks)
  2. Advancing a global health target by five years is as much a political signal as a public-health strategy. Critically evaluate India's TB elimination approach under the NSP 2017–2025. (GS-II, 15 marks)
  3. Robust disease surveillance is a precondition for credible health targets. Discuss in the context of the WHO Global TB Report 2026's treatment of India's incidence estimates. (GS-II/III, 10 marks)

15. Related Topics to Study Next

  • WHO End TB Strategy and its milestones: the yardstick (2020 milestone of a 35% cut in deaths) used to judge India's performance.
  • SDG 3.3: the source of the global 2030 deadline for ending TB.
  • Drug-resistant TB (MDR/RR-TB) and newer short regimens: a key driver of mortality and treatment cost.
  • National Health Mission: the funding and implementation platform for the NTEP.
  • Ni-kshay platform and Ni-kshay Poshan Yojana: India's notification system and nutrition support for TB patients.
  • Undernutrition and TB: the main social driver of TB in India, linked to POSHAN and food security.
  • Integrated Disease Surveillance and health data systems: directly relevant to why the incidence estimate was withheld.
  • Global health financing (Global Fund, the decline in donor money): the context for the 86% domestic share.

16. NCERT Concepts to Revise

  • Tuberculosis (Economy): The disease at the centre of the article; revise its causes, spread and India's share of world cases.
  • Incidence (Economy): India's missed target was about incidence, and WHO withheld its incidence estimate; it differs from deaths.
  • Notification of disease (Economy): Explains why 25.3 lakh notified cases are not the same as true cases or incidence.
  • Global Tuberculosis Report (Economy): The WHO report that triggered the news and withheld India's 2025 estimate pending new data.
  • National TB Elimination Programme (Economy): The programme (renamed from RNTCP in 2020) running India's TB elimination effort under the NSP.
  • WHO End TB Strategy (Economy): Provides the milestones, such as the 35% death cut by 2020, used to judge India.
  • Sustainable Development Goal 3 (Economy): SDG 3.3 sets the 2030 global deadline to end TB, which India tried to beat.
  • Ni-kshay Mitra (Economy): Community adoption of TB patients under the PM TB Mukt Bharat Abhiyaan, launched in 2022.
  • Ni-kshay Portal (Polity): India's digital system for registering and tracking TB patients, behind the notification numbers.
  • Ni-kshay Poshan Yojana (Economy): Cash nutrition support for TB patients, tackling the undernutrition that drives the disease.
  • World Health Organization (Polity): The UN health agency that publishes the report and sets the global TB benchmarks.
  • President of India (Polity): The President launched the TB Mukt Bharat Abhiyaan, a common prelims trap against the 'PM' prefix.

17. Common Errors / Trap Areas

  • 2025 vs 2030: 2025 was India's own target under the NSP. 2030 is the SDG target. Do not attribute 2025 to the WHO or the UN. [1]
  • Notifications are not incidence. The 25.3 lakh figure is notified cases. WHO's estimated incidence for India in 2025 was not published. Do not quote any "2025 incidence rate" for India from this report. [1]
  • Mortality vs incidence targets: the 38% fall is in deaths per lakh, not in cases. The 80% figure is the NSP's incidence target, which was missed. [1]
  • Rounded figures: 28 → 18 per lakh works out to about 36%, but the report states 38%. The gap comes from the unrounded underlying estimates. Quote the official 38%. [1]
  • Programme naming: the programme has been called NTEP since 2020. RNTCP is the old name. The TB Mukt Bharat Abhiyaan (2022) was launched by the President, not the Prime Minister, despite the "PM" prefix. [3][4]

Sources

  1. 1India missed its 2025 TB elimination target. What does the WHO report show? — The Hindu (19 Nov 2026)thehindu.com · tier 4
  2. 2South-East Asia leads global TB cases—WHO urges swift action to address gaps and boost progress — WHO SEARO (18 Nov 2025)who.int · tier 2
  3. 3Ministry of Health and Family Welfare press release, PIBpib.gov.in · tier 1
  4. 4Ministry of Health and Family Welfare press release, PIBpib.gov.in · tier 1
  5. 5TB global report WHO 2025: tuberculosis cases, deaths, India burden — Business Standard (14 Nov 2025)business-standard.com · tier 4
  6. 6TB incidence in India drops by 21% from 237 per lakh population in 2015 to 187 per lakh population in 2024 (PIB, MoHFW)pib.gov.in · tier 1
  7. 7India tops global TB burden in 2024 despite lower incidence: WHO report (Business Standard)business-standard.com · tier 4
  8. 8Ni-kshay model can't be mainstay in eradicating TB by 2025: Parl panel (Business Standard)business-standard.com · tier 4
  9. 9Union Health Minister Unveils Key Initiatives to boost Nutrition Support for TB Patients and their Families (PIB)pib.gov.in · tier 1
  10. 10PM reviews status and progress of TB Mukt Bharat Abhiyaan (PIB)pib.gov.in · tier 1
  11. 11Tuberculosis (TB) fact sheet (WHO)who.int · tier 2
  12. 12Tuberculosis elimination in India: With days left for the national target, are we any close? (Down To Earth)downtoearth.org.in · tier 4
  13. 13Eradicating TB by 2025 in India a tough task: The Global Fund (Business Standard)business-standard.com · tier 4
At the end · practice MCQs
8 questions on this article
Check the answer for each question, or reveal all at once.
Practice MCQs →

Mains Q&A on this note

NCERT concepts in this note

Also on 20 November

All 20 November articles →